These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35258593)

  • 21. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry.
    Jatuworapruk K; Montgomery A; Gianfrancesco M; Conway R; Durcan L; Graef ER; Jayatilleke A; Keen H; Kilian A; Young K; Carmona L; Cogo AK; Duarte-García A; Gossec L; Hasseli R; Hyrich KL; Langlois V; Lawson-Tovey S; Malcata A; Mateus EF; Schafer M; Scirè CA; Sigurdardottir V; Sparks JA; Strangfeld A; Xavier RM; Bhana S; Gore-Massy M; Hausmann J; Liew JW; Sirotich E; Sufka P; Wallace Z; Machado PM; Yazdany J; Grainger R; Robinson PC
    ACR Open Rheumatol; 2022 Nov; 4(11):948-953. PubMed ID: 36000538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Apr; 24(4):615. PubMed ID: 33817990
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective.
    Zamora-Abrahan GT; Salido EO; Lichauco JJT; Gutierrez-Rubio AKM; Rivera-Go ICT; Cortez KJC; Suilan KEA; Villo JGB; Del Rosario AG
    Clin Rheumatol; 2023 Apr; 42(4):1171-1175. PubMed ID: 36637634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data.
    Xu C; Yi Z; Cai R; Chen R; Thong BY; Mu R
    Autoimmun Rev; 2021 Apr; 20(4):102778. PubMed ID: 33609804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Oct; 24(10):1334. PubMed ID: 34596951
    [No Abstract]   [Full Text] [Related]  

  • 26. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Hyrich KL; Gianfrancesco M; Machado PM; Yazdany J; Robinson PC
    Ann Rheum Dis; 2022 Nov; 81(11):e223. PubMed ID: 32895239
    [No Abstract]   [Full Text] [Related]  

  • 27. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 28. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC
    Ann Rheum Dis; 2022 Oct; 81(10):e191. PubMed ID: 32796043
    [No Abstract]   [Full Text] [Related]  

  • 30. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice.
    Liew JW; Bhana S; Costello W; Hausmann JS; Machado PM; Robinson PC; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Grainger R;
    Rheumatology (Oxford); 2021 Jan; 60(1):353-358. PubMed ID: 32789449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and Pediatric Rheumatology: A Comprehensive Study from a Leading Tertiary Center in Saudi Arabia.
    Alqanatish J; Almojali A; Alfadhel A; Albelali A; Ahmed A; Alqahtani A; Alrasheed A; Alsewairi W; Alghnam S
    J Epidemiol Glob Health; 2023 Dec; 13(4):676-684. PubMed ID: 37594620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic].
    Hasseli R; Pfeil A; Hoyer BF; Lorenz HM; Regierer AC; Richter JG; Schmeiser T; Strangfeld A; Voll RE; Krause A; Schulze-Koops H; Müller-Ladner U; Specker C
    Z Rheumatol; 2021 Sep; 80(7):641-646. PubMed ID: 34196793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Mulhearn B
    Ann Rheum Dis; 2023 May; 82(5):e115. PubMed ID: 33648958
    [No Abstract]   [Full Text] [Related]  

  • 34. Correspondence to: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Flood RM; Conway R; Kirby C; Gheta D; Kane DJ; Mullan RH
    Ann Rheum Dis; 2023 Jun; 82(6):e140. PubMed ID: 32816697
    [No Abstract]   [Full Text] [Related]  

  • 35. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Karahan S; Cetinkaya A; Aydin K; Aslan Sirakaya H
    Ann Rheum Dis; 2023 Mar; 82(3):e75. PubMed ID: 32719043
    [No Abstract]   [Full Text] [Related]  

  • 37. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.
    Int J Rheum Dis; 2021 Nov; 24(11):1442. PubMed ID: 34724598
    [No Abstract]   [Full Text] [Related]  

  • 38. Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Andreica I; Kiefer D; Rezniczek GA; Jast R; Buehring B; Kiltz U; Baraliakos X; Braun J
    Ann Rheum Dis; 2022 Oct; 81(10):e189. PubMed ID: 32732243
    [No Abstract]   [Full Text] [Related]  

  • 39. [Severe COVID-19 and outcomes in patients with rheumatic disease].
    Galicia-Lucas UJ; Ramírez-Pérez AA
    Rev Med Inst Mex Seguro Soc; 2021 Jun; 59(2):127-132. PubMed ID: 34231984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of disease activity on the clinical outcome of SARS CoV-2 in patients with underlying rheumatic diseases; data from global rheumatology alliance.
    Perveen S; Samreen S; Gul H; Salim B; Nasim A
    J Pak Med Assoc; 2024 Jun; 74(6):1055-1060. PubMed ID: 38948971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.